GlaxoSmithKline is notifying healthcare professionals and patients that Arixtra (fondaparinux sodium) Starter Kits may contain recalled Triad Group alcohol prep pads. This recall does not affect or involve actual Arixtra. The Starter Kits do not contain Arixtra; they only contain dosing instructions, an education booklet, a needle box, and alcohol prep pads to wipe the injection site. Any Triad alcohol prep found in these kits should not be used.
For more information visit www.fda.gov/Safety/Recalls/ucm239219.htm.